摘要
目的 探讨分析肿瘤患者植入静脉输液港后发生感染的具体原因。方法 研究着手时间与终止
时间分别为 2021 年 2 月和 2022 年 3 月,通过电脑所编辑随机抽选程序作用下,在上述所提及的这段时间
内,选择我院接受治疗的肿瘤患者 105 例作为本次研究的探讨对象,对参与本次研究的所有患者均通过 IVAP
开展相应的临床治疗,对患者接受治疗的过程中出现感染症状的患者进行数据统计,并对患者出现感染症
状的相关原因进行相应的分析。结果 参与本次研究接受植入静脉输液港的 105 例肿瘤患者之中,其中出现
感染症状的患者有 33 例,占有比例为 31.43%,对发生与未发生感染症状的患者进行比较,其中发现患者手
术时长、使用时间及其频率、有无糖尿病史存在、体质量均存在差异性(P<0.05)。结论 对于出现肿瘤症
状的患者而言,对相应患者通过植入静脉输液港的方式开展相应的临床治疗工作,其出现感染症状的主要
因素之中,包含了患者穿刺部位、疾病类型、使用植入静脉输液港的时间以及频率等一系列的情况,同时
也与患者自身的实际情况有着较大的关联性,临床上需要对患者进行密切的监查,能够对输液港使用过程
中所出现的感染症状得到一定程度的控制。
关键词: 肿瘤;植入静脉输液港;感染
Abstract
Objective To explore and analyze the specific causes of infection in tumor patients after
implantation of intravenous infusion port. Methods The start time and end time of the study are February 2021 and
March 2022, respectively. Under the influence of the random selection program edited by the computer, 105 tumor
patients who received treatment in our hospital during the above mentioned period were selected as the objects of
this study. All patients participating in this study received corresponding clinical treatment through IVAP. The data
of patients with symptoms of infection in the process of receiving treatment were collected, and the relevant causes
of symptoms of infection were analyzed accordingly. Results Among 105 tumor patients who were implanted at
the port of intravenous infusion in this study, 33 patients showed symptoms of infection, accounting for 31.43%.
Comparison was made between patients with and without symptoms of infection. It was found that there were
differences in operation duration, use time and frequency, diabetes history and body weight (P<0.05). Conclusion
For patients with tumor symptoms, the corresponding clinical treatment should be carried out through the
implantation of intravenous infusion port. The main factors for the occurrence of infection symptoms include a
series of situations such as the patient's puncture site, disease type, time and frequency of using the implantation
port of intravenous infusion, etc., which are also closely related to the actual situation of the patient. In clinic,
patients need to be closely monitored to control the symptoms of infection during the use of infusion port.
Key words: tumor; Implantation of intravenous infusion port; infection
参考文献 References
[1] 冯娜娜,林美华,王彦芬,等. 化疗期恶性肿瘤病人植入式静脉输液港感染发生原因分析及其防护措施[J]. 全科护理,2021,19(21):2998-3000.
[2] 潘欢,陈晓燕,张婷,等. 实体瘤化疗患者植入式静脉输液港治疗的相关感染并发症及危险因素分析[J]. 现代肿瘤医学,2021,29(8):1382-1386.
[3] 黄月娥,李志根,李丹莉,等. 高龄患者植入静脉输液港并发感染相关影响因素分析[J]. 广州医药,2020,51(4):71-74.
[4] 王燕娜,华红霞. 消化道肿瘤患者静脉输液港感染的危险因素 及 防 护 对 策 分 析 [J]. 国 际 医 药 卫 生 导 报 ,2020,26(21):3357-3359.
[5] 杨婷婷,张春花,苏爱江,等. 肿瘤化疗患者应用植入式静脉输液港发生堵塞的原因与防护对策[J]. 护理实践与研究,2020,17(10):137-138.
[6] 林小芳,关金华,陈慧华. 植入式静脉输液港(VAP)进行肿瘤化疗患者的并发症发生原因及护理对策[J]. 中外医疗,2020,39(25):111-113.
[7] 徐燕,何灵慧,钱玉兰. 肿瘤病人应用植入式静脉输液港的临床 护 理 分 析 [J]. 实 用 临 床 护 理 学 电 子 杂 志 ,2020,5(19):34-35.
[8] 雷海云, 钱亚萍, 李淑颖, et al. 肿瘤患者化疗中应用植入式静脉输液港的临床效果[J]. 中西医结合护理(中英文),2021,7(1):86-88.